Park Place Capital Corp Has $32,000 Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA)

Park Place Capital Corp lessened its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 26.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,840 shares of the company’s stock after selling 652 shares during the period. Park Place Capital Corp’s holdings in Privia Health Group were worth $32,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in PRVA. International Assets Investment Management LLC grew its holdings in Privia Health Group by 2,721.7% during the fourth quarter. International Assets Investment Management LLC now owns 7,139 shares of the company’s stock valued at $164,000 after purchasing an additional 6,886 shares during the last quarter. Bleakley Financial Group LLC acquired a new stake in shares of Privia Health Group in the fourth quarter worth $305,000. Allspring Global Investments Holdings LLC grew its stake in shares of Privia Health Group by 30.7% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 8,214 shares of the company’s stock worth $189,000 after acquiring an additional 1,928 shares during the last quarter. Simplicity Solutions LLC acquired a new stake in shares of Privia Health Group in the fourth quarter worth $305,000. Finally, WCM Investment Management LLC grew its stake in shares of Privia Health Group by 9.3% in the fourth quarter. WCM Investment Management LLC now owns 549,087 shares of the company’s stock worth $13,145,000 after acquiring an additional 46,556 shares during the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on PRVA shares. Barclays lowered their price objective on shares of Privia Health Group from $22.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Monday, May 20th. Citigroup assumed coverage on shares of Privia Health Group in a research note on Monday, April 22nd. They set a “buy” rating and a $25.00 price target on the stock. Robert W. Baird assumed coverage on shares of Privia Health Group in a research note on Thursday, May 30th. They set an “outperform” rating and a $23.00 price target on the stock. Truist Financial decreased their price target on shares of Privia Health Group from $28.00 to $24.00 and set a “buy” rating on the stock in a research note on Wednesday, May 15th. Finally, Evercore ISI decreased their price target on shares of Privia Health Group from $23.00 to $20.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 9th. Two investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $24.54.

Insider Activity at Privia Health Group

In other Privia Health Group news, Director Adam Boehler purchased 5,306 shares of the business’s stock in a transaction that occurred on Wednesday, May 29th. The stock was acquired at an average cost of $16.50 per share, with a total value of $87,549.00. Following the completion of the acquisition, the director now directly owns 5,773,158 shares of the company’s stock, valued at approximately $95,257,107. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. In other Privia Health Group news, EVP Thomas Bartrum sold 1,506 shares of the business’s stock in a transaction dated Friday, May 10th. The stock was sold at an average price of $17.88, for a total transaction of $26,927.28. Following the completion of the sale, the executive vice president now directly owns 102,356 shares of the company’s stock, valued at approximately $1,830,125.28. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Adam Boehler acquired 5,306 shares of the company’s stock in a transaction on Wednesday, May 29th. The shares were purchased at an average cost of $16.50 per share, with a total value of $87,549.00. Following the completion of the acquisition, the director now directly owns 5,773,158 shares in the company, valued at approximately $95,257,107. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 293,235 shares of company stock valued at $4,745,481 and sold 17,607 shares valued at $314,813. 14.20% of the stock is currently owned by company insiders.

Privia Health Group Trading Down 2.5 %

Shares of Privia Health Group stock traded down $0.51 during trading on Friday, reaching $19.99. The company’s stock had a trading volume of 655,911 shares, compared to its average volume of 677,748. The stock has a 50-day moving average price of $17.96 and a two-hundred day moving average price of $19.06. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $28.00. The stock has a market capitalization of $2.39 billion, a P/E ratio of 133.27, a price-to-earnings-growth ratio of 3.38 and a beta of 0.78.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings results on Thursday, May 9th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.03). Privia Health Group had a net margin of 1.11% and a return on equity of 3.13%. The business had revenue of $415.24 million during the quarter, compared to the consensus estimate of $435.07 million. As a group, sell-side analysts anticipate that Privia Health Group, Inc. will post 0.19 EPS for the current fiscal year.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.